...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Alleviating the Intestinal Absorption of Rhein in Rhubarb through Herb Compatibility in Tiaowei Chengqi Tang in Caco-2 Cells
【24h】

Alleviating the Intestinal Absorption of Rhein in Rhubarb through Herb Compatibility in Tiaowei Chengqi Tang in Caco-2 Cells

机译:通过调配成气汤中Caco-2细胞的中草药相容性减轻大黄中大黄酸的肠道吸收

获取原文

摘要

Tiaowei Chengqi Tang (TWCQT) is composed of rhubarb, processed liquorice, and Natrii Sulfas, which is used as a purgative in traditional Chinese medicine (TCM). This study focused on the intestinal absorption of rhein in disassembly of the TWCQT extracts through the Caco-2 cell monolayer model to explicate the possible detoxification mechanism of herb-herb compatibility in TWCQT. The results showed that the intestinal absorption of rhein occurred through active diffusion, and rhein might be composed of breast cancer resistance protein (BCRP) substrates. The extract of processed liquorice increased the exclusion rate and reduced intracellular uptake of rhein. The consistent results observed in TWCQT further implied that processed liquorice in TWCQT could suppress the absorption of rhein across the Caco-2 cell monolayer. It has therefore been concluded that the active ingredients of processed liquorice may play a critical role in reducing the intestinal absorption of rhein to alleviate the toxicity of rhubarb in TWCQT. Because of BCRP’s involvement in rhein transport, we conjectured that some components in processed liquorice could inhibit the transport of rhein, possibly by mediating BCRP. These results would provide new insight into this ancient drug combination in toxicity reduction and clinical use.
机译:调胃成气汤(TWCQT)由大黄,加工的甘草和Natrii Sulfas组成,后者在中药(TCM)中用作泻药。这项研究集中在通过Caco-2细胞单层模型分解TWCQT提取物中的大黄酸的肠道吸收,以阐明TWCQT中草药-草药相容性的可能解毒机理。结果表明,大黄酸的肠道吸收是通过主动扩散发生的,并且大黄酸可能是由乳腺癌抗性蛋白(BCRP)底物组成的。加工后的甘草提取物增加了排泄率并降低了大黄酸的细胞内摄取。在TWCQT中观察到的一致结果进一步暗示,在TWCQT中加工的甘草可以抑制大黄酸跨Caco-2细胞单层的吸收。因此,可以得出结论,加工后的甘草的活性成分可能在减少大黄酸的肠道吸收,减轻大黄在TWCQT中的毒性方面起关键作用。由于BCRP参与了大黄酸的运输,我们推测加工甘草中的某些成分可能通过介导BCRP来抑制大黄酸的运输。这些结果将为这种古老的药物组合降低毒性和临床应用提供新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号